Nintedanib in the prevention of radiation-induced lung injury in patients with unresectable stage II-III NSCLC: A protocol for a randomized, multicenter, control group study.

Ai Cui, Anhui Shi, Lei Deng, Yanyan Sun, Jiayi Yu, Xinrong Lian, Ziyue Zhao

Open source

DOI
10.1371/journal.pone.0356205
Published
0
Container
PLoS ONE
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0356205,
  title = {Nintedanib in the prevention of radiation-induced lung injury in patients with unresectable stage II-III NSCLC: A protocol for a randomized, multicenter, control group study.},
  author = {Ai Cui and Anhui Shi and Lei Deng and Yanyan Sun and Jiayi Yu and Xinrong Lian and Ziyue Zhao},
  year = {2026},
  journal = {PLoS ONE},
  doi = {10.1371/journal.pone.0356205},
  url = {https://doi.org/10.1371/journal.pone.0356205}
}

RIS

TY  - JOUR
TI  - Nintedanib in the prevention of radiation-induced lung injury in patients with unresectable stage II-III NSCLC: A protocol for a randomized, multicenter, control group study.
AU  - Ai Cui
AU  - Anhui Shi
AU  - Lei Deng
AU  - Yanyan Sun
AU  - Jiayi Yu
AU  - Xinrong Lian
AU  - Ziyue Zhao
PY  - 2026
JO  - PLoS ONE
DO  - 10.1371/journal.pone.0356205
UR  - https://doi.org/10.1371/journal.pone.0356205
ER  - 

APA

Cui, A., Shi, A., Deng, L., Sun, Y., Yu, J., Lian, X., & Zhao, Z. (2026). Nintedanib in the prevention of radiation-induced lung injury in patients with unresectable stage II-III NSCLC: A protocol for a randomized, multicenter, control group study.. PLoS ONE. https://doi.org/10.1371/journal.pone.0356205

Source records